Expression of slow skeletal TnI in adult mouse hearts confers metabolic protection to ischemia

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 2, 2011, Pages 236-243

  Pound, Kayla M ^a   Arteaga, Grace M ^a   Fasano, Mathew ^a   Wilder, Tanganyika ^a   Fischer, Susan K ^a   Warren, Chad M ^a   Wende, Adam R ^b   Farjah, Mariam ^a   Abel, E Dale ^b   Solaro, R John ^a   Lewandowski, E Douglas ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine triphosphate (ATP); AMP activated protein kinase (AMPK); Glycolysis; NMR spectroscopy; Troponin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ALANINE; FETAL MYOFILAMENT PROTEIN; GLUCOSE; GLYCOGEN; LACTIC ACID; MUSCLE PROTEIN; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FETUS HEART; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; HYPOXIA; MALE; METABOLIC ADAPTATION; METABOLIC PARAMETERS; METABOLIC PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLYCOGEN; GLYCOLYSIS; MALE; MICE; MICE, TRANSGENIC; MUSCLE FIBERS, SLOW-TWITCH; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PHOSPHORYLATION; TROPONIN I;

EID: 79959524652     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.05.014     Document Type: Article

References (41)

1. Oka T., Xu J., Molkentin J.D. Re-employment of developmental transcription factors in adult heart disease. Semin Cell Dev Biol 2007, 18:117-131.
2. Thum T., Galuppo P., Wolf C., Fiedler J., Kneitz S., van Laake L.W. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007, 116:258-267.
3. Du J., Nan C., Huang J.J., Zhang C., Liu J., Jia P., et al. Functional characterization of mouse fetal TnI gene promoters in myocardial cells. J Biomed Sci 2008, 15:605-613.
4. Sucharov C., Bristow M.R., Port J.D. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardio 2008, 45:185-192.
5. Taegtmeyer H., Sen S., Vela D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann NY Acad Sci 2010, 1188:191-198.
6. Arteaga G.M., Palmiter K.A., Leiden J.M., Solaro R.J. Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I. J Physiol 2000, 526:541-549.
7. Arteaga G.M., Warren C.M., Milutinovic S., Martin A.F., Solaro R.J. Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction. Am J Physiol Heart Circ Physiol 2005, 289:H2183-H2192.
8. Pauly D.F., Kirk K.A., McMillin J.B. Carnitine palmitoyltransferase in cardiac ischemia: a potential site for altered fatty acid metabolism. Circ Res 1991, 68:1085-1094.
9. Apstein C.S. Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury. Am Heart J 2000, 139:S107-S114.
10. Lopaschuk G. Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J 2000, 139:S115-S119.
11. Lewandowski E.D., Kudej R.K., White L.T., O'Donnell J.M., Vatner S.F. Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction. Circulation 2002, 105:367-372.
12. Hoerter J. Changes in the sensitivity to hypoxia and glucose deprivation in the isolated perfused rabbit heart during perinatal development. Pfugers Arch 1976, 363:1-6.
13. Hoerter J., Opie L.H. Perinatal changes in glycolytic function in response to hypoxia in the incubated or perfused rat heart. Biol Neonate 1978, 33:144-161.
14. Ascuitto R.J., Ross-Ascuitto N.T. Substrate metabolism in the developing heart. Semin Perinatol 1996, 20:542-563.
15. Patterson A.J., Zhang L. Hypoxia and fetal heart development. Curr Mol Med 2010, 10:653-666.
16. Lewandowski E.D. Nuclear magnetic resonance evaluation of metabolic and respiratory support of workload in intact rabbit hearts. Circ Res 1992, 70:576-582.
17. Gutmann I., Wahlefeld A.W. l-(+)-Lactate. Determination with lactate dehydrogenase and NAD. Methods of enzymatic analysis 1994, 1464-1468. Academic Press, New York. H.U. Bergmeyer (Ed.).
18. Lewandowski E.D., Johnston D.L., Roberts R. Effects of inosine on glycolysis and contracture during myocardial ischemia. Circ Res 1991, 68:578-587.
19. Damico L.A., White L.T., Yu X., Lewandowski E.D. Chemical versus isotopic equilibrium and the metabolic fate of glycolytic end products in the heart. J Mol Cell Cardiol 1996, 28:989-999.
20. Lewandowski E.D. Metabolic heterogeneity of carbon substrate utilization in mammalian heart: NMR determinations of mitochondrial versus cytosolic compartmentation. Biochemistry 1992, 31:8916-8923.
21. Taegmeyer H., Roberts A.F., Raine A.E. Energy metabolism in reperfused heart muscle: metabolic correlates to return of function. J Am Coll Cardiol 1985, 6:864-870.
22. Yates L.D., Greaser M.L. Quantitative determination of myosin and actin in rabbit skeletal muscle. J Mol Biol 1983, 168:123-141.
23. Abel E.D., Graveleau C., Betuing S., Pham M., Reay P.A., Kandror V., et al. Regulation of insulin-responsive aminopeptidase expression and targeting in the insulin-responsive vesicle compartment of glucose transporter isoform 4-deficient cardiomyocytes. Mol Endocrinol 2004, 18:2491-2501.
24. Warren C.M., Arteaga G.M., Rajan S., Ahmed R.P., Wieczorek D.F., Solaro R.J. Use of 2-d dige analysis reveals altered phosphorylation in a tropomyosin mutant (glu54lys) linked to dilated cardiomyopathy. Proteomics 2008, 8:100-105.
25. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987, 262:10035-10038.
26. Wende A.R., Soto J., Olsen C.D., Pires K.M., Schell J.C., Larrieu-Lahargue F., et al. Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice. Endocrinology 2010, 151(8):3536-3542.
27. Banke N.H., Wende A.R., Leone T.C., O'Donnell J.M., Abel E.D., Kelly D.P., et al. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPAR?. Circ Res 2010, 107(2):233-241.
28. Sena S., Rasmussen I.R., Wende A.R., McQueen A.P., Theobald H.A., Wilde N., et al. Cardiac hypertrophy caused by PPAR? agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology 2007, 148(12):6047-6053.
29. Lewandowski E.D., Devous M.D., Nunnally R.L. High energy phosphates and function in isolated, working rabbit hearts. Am J Physiol Heart Circ Physiol 1987, 253:H1215-H1223.
30. Lewandowski E.D., White L.T. Pyruvate dehydrogenase influences postischemic heart function. Circulation 1995, 91:2071-2079.
31. Taegtmeyer H., Peterson M.B., Ragavan V.V., Ferguson A.G., Lesch M. De novo alanine synthesis in isolated oxygen-deprived rabbit myocardium. J Biol Chem 1971, 252:5010-5018.
32. Vanoverschelde J.L., Janier M.F., Bakke J.E., Marshall D.R., Bergmann S.R. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994, 267:H1785-H1794.
33. He H., Javadpour M.M., Latif F., Tardiff J.C., Ingwall J.S. R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts. Biophys J 2007, 93:1834-1844.
34. Day S.M., Westfall M.V., Fomicheva E.V., Hoyer K., Yasuda S., La Cross N.C., et al. Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med 2006, 12:181-189.
35. Rice R., Guinto P., Dowell-Martino C., He H., Hoyer K., Krenz M., et al. J Mol Cell Cardiol 2010, 48:979-988.
36. Griffin J., O'Donnell J.M., White L.T., Hajjar R.J., Lewandowski E.D. Postnatal expression and activity of the 2-oxoglutarate malate carrier in intact hearts. Am J Physiol: Cell Physiol 2000, 279:C1704-C1709.
37. Yatscoff M.A., Jaswal J.S., Grant M.R., Greenwood R., Lukat T., Beker D.L., et al. Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart. Pediatr Res 2008, 64:643-647.
38. Tian R., Musi N., D'Agostino J., Hirshman M.F., Goodyear L.J. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001, 104:1664-1669.
39. Frederich M., Balschi J.A. The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J Biol Chem 2002, 277:1928-1932.
40. Russell R.R., Bergeron R., Shulman G.I., Young L.H. Translocation of myocardial GLUT4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol: Heart Circ Physiol 1999, 277:H643-H649.
41. Jørgensen S.B., Nielsen J.N., Birk J.B., Olsen G.S., Viollet B., Andreelli F., et al. The alpha2 5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes 2004, 5:3074-3081.